Ocular Therapeutix (OCUL) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to $71.3 million.

  • Ocular Therapeutix's Non-Current Debt rose 413.25% to $71.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $71.3 million, marking a year-over-year increase of 413.25%. This contributed to the annual value of $71.3 million for FY2025, which is 413.25% up from last year.
  • Latest data reveals that Ocular Therapeutix reported Non-Current Debt of $71.3 million as of Q4 2025, which was up 413.25% from $70.6 million recorded in Q3 2025.
  • In the past 5 years, Ocular Therapeutix's Non-Current Debt ranged from a high of $71.3 million in Q4 2025 and a low of $14.9 million during Q1 2021
  • Moreover, its 5-year median value for Non-Current Debt was $45.2 million (2023), whereas its average is $46.0 million.
  • Per our database at Business Quant, Ocular Therapeutix's Non-Current Debt plummeted by 3515.03% in 2021 and then surged by 18808.31% in 2024.
  • Quarter analysis of 5 years shows Ocular Therapeutix's Non-Current Debt stood at $25.0 million in 2021, then increased by 1.03% to $25.3 million in 2022, then soared by 160.47% to $65.8 million in 2023, then rose by 4.13% to $68.5 million in 2024, then rose by 4.13% to $71.3 million in 2025.
  • Its Non-Current Debt stands at $71.3 million for Q4 2025, versus $70.6 million for Q3 2025 and $69.9 million for Q2 2025.